Therapie

Article	Citations
Uses of pharmacovigilance databases: An overview	104
Pharmacovigilance and drug safety: Fair prescribing and clinical research	53
Safety data and withdrawal of hepatotoxic drugs	53
Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations	46
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)	39
Efficacy of COVID-19 vaccines: From clinical trials to real life	31
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres	25
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge	23
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy	22
Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19	18
Skin cancers under Janus kinase inhibitors: A World Health Organization drug safety database analysis	17
Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials	14
Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database	13
COVID-19 vaccines: A perspective from social pharmacology	12
Innovative approaches in CNS drug discovery	12
Central diabetes insipidus revealing a hypophysitis induced by SARS-CoV-2 vaccine	11
Thrombotic events after AstraZeneca vaccine: What if it was related to dysfunctional immune response?	11
Epidemiology and economic burden of “serious” adverse drug reactions: Real-world evidence research based on pharmacovigilance data	10
Warning on increased serious health complications related to non-medical use of nitrous oxide	10
Platform trials	10
Incretin-based drugs and intestinal obstruction: A pharmacovigilance study	10
Doping with aromatase inhibitors and oestrogen receptor modulators in steroid users: Analysis of a forum to identify dosages, durations and adverse drug reactions	9
A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy	9
Vaccines and Bell's palsy: A narrative review	9
Alteration of the pharmacokinetics of aminoglycosides by adsorption in a filter during continuous renal replacement therapy. An in vitro assessment	9

Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature	9
Place of patient-reported outcomes & experiences measurements (PROMS/PREMS) in the assessment and pricing of Health technologies in France	8
Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19	8
Efficacy of metformin on glycemic control and weight in drug-naive type 2 diabetes mellitus patients: A systematic review and meta-analysis of placebo-controlled randomized trials	8
Penetration rate of anti-TNF biosimilars and savings at 5 years after their introduction in French hospitals	8
Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022	8
Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021	8
Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice	8
Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemic	7
Drug-induced meningitis: A review of the literature and comparison with an historical cohort of viral meningitis cases	7
Calcium channel blocker exposure and psoriasis risk: Pharmacovigilance investigation and literature data	7
Consommation de substances chez les jeunes : du médicament aux substances illicites	7
Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol	7
COVID-19 vaccines and pregnancy: What do we know?	7
A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19	6
Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database	6
Synthèse des recommandations de l’International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) sur le suivi thérapeutique pharmacologique du tacrolimus	6
Sex differences: From preclinical pharmacology to clinical pharmacology	6
Are β-lactam concentrations adequate in severe sepsis and septic shock in children?	6
Profils d’effets indésirables sous abiratérone et enzalutamide : analyse descriptive des données de la base nationale de pharmacovigilance	6
Global research output in ‘pharmacovigilance’ during 2010–2020	6
Les politiques de partage de données des financeurs d’essais cliniques en France	5
Adverse drug reactions in pregnant women: Do they differ from those in non-pregnant women of childbearing age?	5
The need to shed light on potential insidious SARS-CoV-2 post-vaccination pituitary lesions	5
Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19	5
The French pharmacovigilance surveys: A French distinctiveness, a real input	5
Analyse des seringues usagées : un reflet de la consommation de substances psychoactives par les usagers de drogues par voie intraveineuse ?	5
Project rebuild the evidence base (REB): A method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients	5
Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives	5
Atteintes musculaires et levure de riz rouge : analyse des données de la base nationale de pharmacovigilance et revue de la littérature	5
Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series	5
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective	5
The “old” cytotoxic drugs, the basis of anti-cancer treatments	4
Déclaration des erreurs médicamenteuses dans les recherches portant sur le médicament : place du pharmacien des essais cliniques ?	4
Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic	4
Drug consumption during prolonged lockdown due to Covid-19 as observed in French addiction center	4
Non-medical use of baclofen: A case series and review of the literature	4
Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey	4
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects	4
Is caspofungin efficient to treat invasive candidiasis requiring continuous veno-venous hemofiltration? A case report	4
Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance study	4
Chronic spontaneous urticaria following vaccination against SARS-CoV-2	4
Pharmacologie du cannabidiol : points de vigilance, conséquences et risques chez l’homme	4
Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study	4
Adherence after treatment switch from a multiple tablet antiretroviral regimen to a single tablet antiretroviral regimen	4
Les médicaments potentiellement inappropriés : adaptation de la liste EU(7)PIM à la pratique médicale française	4
A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)	4
Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®	4
Drug-induced hearing loss: Listening to the latest advances	4
Quality of evidence of the efficacy of therapeutic interventions on patient-important outcomes in Cochrane's systematic reviews’ abstracts: A survey	4

Utilisation et gestion des inhibiteurs de la pompe à protons : une étude observationnelle	4
Pharmacotherapy of substance use disorders in the neuroscience-based nomenclature (NbN)	3
Les solutions numériques en santé, quelles valeurs apportées, quels mécanismes de financement et quelles évaluations ?	3
Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)	3
Cinderella side effect: Intravenous corticosteroid-induced bradycardia	3
Towards personalized pharmacology: Antipsychotics and schizophrenia	3
Drug-induced hyperglycemia and diabetes	3
DRESS syndrome with cholecystitis in a child: A case report and literature review	3
Prescription errors by emergency physicians for inpatients are associated with emergency department length of stay	3
Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses’ infections	3
Raising public awareness about the misuse of predatory journals: One year after the “hydroxychloroquine and push-scooters accidents” hoax	3
Suivi thérapeutique pharmacologique de l’olanzapine	3
Enhancing the role played by clinical pharmacists in psychiatric settings to better integrate clinical psychopharmacology into the decision-making process	3
Severe serotonin syndrome caused by an interaction between an antidepressant and a cough syrup	3
Trente ans d’abus de néfopam en France	3
Androgens, QT, sex and ventricular repolarization–a double-edged sword: A case series	3
Bacterial infections in people who inject psychoactive substances: An observational study in a French university hospital	3
DPP-4 inhibitors and severe course of illness in patients with COVID-19	3
Cluster headache after COVID-19 vaccination with Comirnaty: A signal in pharmacovigilance database	3
Les essais plateformes	3
Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France	3
Minors and young adult's hospitalizations after “chimique” consumption in Mayotte Island: Which substances are involved?	3
Complications infectieuses liées à l’utilisation du propofol : une nouvelle série de cas et revue de la littérature	3
The discovery of hypoglycaemic sulphonamides – Montpellier, 1942	3
Daily practices regarding safety monitoring of low-dose methotrexate and comparison to guidelines: A population-based cohort study	3
Pharmacokinetics of ceftolozane/tazobactam continuous infusion on renal replacement therapy: A pediatric case report	3
Pharmacokinetics and therapeutic drug monitoring of anticancer protein/kinase inhibitors	3
Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss – An observational study using the EFEMERIS database	3
Interactions médicamenteuses avec la colchicine, les contre-indications sont-elles bien respectées ? Étude descriptive des prescriptions en Bretagne à partir des données de l’Assurance maladie	3
Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic	3
Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020	3
Refractory non-variceal upper gastrointestinal bleeding in a liver-transplant patient: Everolimus withdrawal should be considered	3
Relapsing generalized bullous fixed drug eruption: A severe and avoidable cutaneous drug reaction. Three case reports	3
Meningiomas after cyproterone acetate exposure: Case reports in twin sisters	3
An atypical Ramsey Hunt syndrome after covid 19 immunization	3
What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?	3
Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted	3
Immunotherapies in acute leukemia	3
Imagerie TEP pour l’étude des répercussions fonctionnelles de la P-glycoprotéine en neuropharmacocinétique	3
Suivi thérapeutique pharmacologique de la clozapine	3
Pharmaciens d’officine, étudiants en pharmacie et demandes de médicaments à base de codéine : étude observationnelle	3
A historical cohort study to investigation of statins safety in COVID-19 hospitalized patients	3
Un tour d’horizon du développement de biomarqueurs pour les anticorps PD-1 et PD-L1 en cancérologie	2
Myocardial infarction in relation to colchicine poisoning: A precipitating cause of refractory toxic cardiogenic shock	2
Innovative approaches in CNS clinical drug development: Quantitative systems pharmacology	2
Usages de substances de synthèse en France et en Europe	2
Étude observationnelle des déclarations de liens d’intérêts au Congrès de la médecine générale France et liens d’intérêts des médecins intervenants	2
Drug-induced cardiac toxicity and adverse drug reactions, a narrative review	2
Adverse drug reaction monitoring: Doing it the French way – Act II	2
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION project	2
Évaluation du potentiel d’abus et de dépendance de la quétiapine (Xeroquel®)	2
Pourquoi et comment améliorer l’information des patients et de leurs aidants au bon usage de leurs dispositifs médicaux tout au long du parcours de soin ?	2
Interaction entre amoxicilline/acide clavulanique et fluindione : à propos de deux cas	2
Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!	2
Isotonitazene, a synthetic opioid from an emerging family: The nitazenes	2
Cutaneous adverse drug reactions	2
Proportion and conditions of use of intranasal take-home naloxone kits: A retrospective study in two French outpatient addiction centers, 2016–2020	2
Ambulatory drug changes in the elderly after hospital discharge: A cohort study	2
Parental self-medication with antibiotics in a Tunisian pediatric center	2
Contributions of animal models of cognitive disorders to neuropsychopharmacology	2
The 2019 Global Initiative for Asthma report: Evidence-based or evidence-biased medicine?	2
Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemic	2
Use of triptans during pregnancy? With caution!	2
Hypoglycémie sévère et arrêt cardiorespiratoire attribués au tramadol – à propos d’un cas	2
Bismuth encephalopathy and mineral waters: a new hypothesis on bismuth absorption	2
Letrozole induced visual hallucination	2
Modifications pharmacocinétiques liées à une infection aiguë. Exemples issus de la pandémie de SARS-CoV-2	2
Efficacy and safety of neural stem cell therapy for spinal cord injury: A systematic literature review	2
General practitioners’ compliance with benzodiazepine discontinuation guidelines in patients treated with long-term lorazepam: A case-vignette cross-sectional survey	2
Impact of diabetes mellitus on rifampicin's plasma concentration and bioavailability in patients with tuberculosis: A systematic review and meta-analysis study	2
Référentiel ECRIN pour la conformité aux bonnes pratiques de gestion des données des essais cliniques multinationaux	2
Un exemple de réorganisation dans le fonctionnement d’un Centre d’investigations cliniques en période de confinement national suite à la pandémie COVID-19	2
Évolution des comportements de consommation de produits psychoactifs illicites ou détournés de leur usage médicamenteux chez les femmes enceintes en France : analyse des données OPPIDUM de 2005 à 2018	2
The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humans	2
Drug-induced glomerular diseases	2
Consommer du CBD ou conduire, faut-il choisir ?	2
Delayed thrombocytopenia following administration of abciximab: Pharmacovigilance survey and literature review	2
Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in France	2
Drug-induced psychiatric disorders: A pharmacovigilance update	2
A case of iatrogenic vitamin D toxicity revealed by drug reconciliation	2

Paediatric drug development and evaluation: Existing challenges and recommendations	2
Hypophosphatémie et fer injectable : à propos d’un cas et revue de la littérature	2
Pulmonary hemorrhage in a neonate born to a woman with cystic fibrosis treated with targeted cystic fibrosis transmembrane conductance regulator modulator elexacaftor–tezacaftor–ivacaftor during pregn	2
Balneotherapy in spondyloarthropathy: A systematic review	2
Pharmacology and pharmacovigilance of protein kinase inhibitors	2
Leukocytoclastic vasculitis mimicking photosensitivity induced by thiamazole	2
Acute myocarditis during carboplatin and pemetrexed chemotherapy for lung adenocarcinoma	2
Brain circuits at risk in psychiatric diseases and pharmacological pathways	2
Spiderweb-like pattern: A novel dermoscopic feature in photo-onycholysis induced by doxycycline?	2
Case report: Confirming a diagnosis of severe olmesartan-associated enteropathy	2
Health crisis: What opportunities for clinical drug research?	2
Prévention des surdoses opioïdes et diffusion de naloxone (programme POP) : résultats d’un état des lieux réalisé auprès des structures d’addictologie	2
Green tea and hepatoxicity: Two case reports	2
Hospitalisations après consommation de substances psychoactives pendant la pandémie de COVID-19	2
Olmesartan-associated enteropathy: Belgian survey	2